| Patient | Elizabeth Barrett Browning |
|---|---|
| Date of birth | 1987-03-06 |
| Identifiers | MRN HR-NI026-SYN; SSN (made up) 000-26-4157 |
| Document date | 2026-03-23 |
| Author | Clementine Haverford-Asante, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
One-week review, seen the same morning by pulmonology with CT of the chest and spirometry. [S]
Ms. Barrett Browning returns one week after her first visit and was seen this morning by Dr. Ellesmere-Park of pulmonology, who reviewed her CT and spirometry. Her three sputum samples were negative for acid-fast bacilli on smear and by nucleic acid amplification, her interferon-gamma release assay and HIV test were negative, and the routine culture grew Haemophilus influenzae. She has worn a mask with visitors and is relieved to hear that tuberculosis is very unlikely. Her cough and sputum are unchanged, about four tablespoons a day, and she saw one thin streak of blood three days ago. She takes morphine solution 5 mL twice daily as before and has used no extra. She has booked her first grief session for this week. She started vitamin D. [S]
| Element | Detail |
|---|---|
| Results since last visit | Three smears and NAAT negative; IGRA negative; HIV negative; sputum culture Haemophilus influenzae, beta-lactamase negative |
| Symptoms | Unchanged cough with four tablespoons of sputum a day; one streak of blood three days ago |
| Testing today | CT of the chest with contrast; spirometry before and after bronchodilator; immunoglobulins, total IgE and Aspergillus IgE |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or night sweats |
| Respiratory | Positive | Daily productive cough; one streak of blood; breathless on one flight of stairs |
| Cardiovascular | Positive | Palpitations at night now and then; no chest pain |
| Psychiatric | Positive | Mood heavy; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Morphine sulfate 2 mg/mL oral solution, 5 mL (10 mg) by mouth twice daily, morning and bedtime (20 mg a day; long-standing prescription, continued) | 5 mL (10 mg) twice daily, morning and bedtime | Oral route | 2019-03-01 to 2026-04-19 | completed | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeat in 2 to 3 minutes in the other nostril if no response; call 911 | As needed for suspected overdose; keep two devices at home | Nasal route | 2026-03-16 | active | S |
| Cholecalciferol (vitamin D3) 1000 unit (25 mcg) oral tablet, two tablets (2000 units) by mouth daily | Two tablets daily | Oral route | 2026-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-23 | Body height | 157 | cm | S |
| 2026-03-23 | Body weight | 41.6 | kg | S |
| 2026-03-23 | Body mass index (BMI) [Ratio] | 16.9 | kg/m2 | S |
| 2026-03-23 | Systolic blood pressure | 100 | mm[Hg] | S |
| 2026-03-23 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 2026-03-23 | Heart rate | 92 | /min | S |
| 2026-03-23 | Respiratory rate | 18 | /min | S |
| 2026-03-23 | Body temperature | 36.8 | Cel | S |
| 2026-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-23 | FEV1 --post bronchodilation | 2.02 | L | Lower limit of normal for her age, sex and height | Low | S |
| 2026-03-23 | FEV1 measured/predicted | 74 | % | >=80% | Low | S |
| 2026-03-23 | Forced vital capacity [Volume] Respiratory system --post bronchodilation | 2.93 | L | Lower limit of normal for her age, sex and height | Normal | S |
| 2026-03-23 | FEV1/FVC --post bronchodilation | 0.69 | {ratio} | Lower limit of normal for her age about 0.72 | Low | S |
| 2026-03-23 | IgG [Mass/volume] in Serum or Plasma | 1180 | mg/dL | 700-1600 mg/dL | Normal | S |
| 2026-03-23 | IgA [Mass/volume] in Serum or Plasma | 236 | mg/dL | 70-400 mg/dL | Normal | S |
| 2026-03-23 | IgM [Mass/volume] in Serum or Plasma | 142 | mg/dL | 40-230 mg/dL | Normal | S |
| 2026-03-23 | IgE [Units/volume] in Serum or Plasma | 38 | [IU]/mL | <=100 [IU]/mL | Normal | S |
| 2026-03-23 | Aspergillus fumigatus IgE Ab [Units/volume] in Serum | 0.08 | k[IU]/L | Below 0.35 kU/L: negative | Normal | S |
Vital signs recorded on 2026-03-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin, alert; weight 41.6 kg; oxygen saturation 96% on room air |
| Respiratory | Coarse crackles at the left base and left mid-zone that shift with coughing; no wheeze; no clubbing |
| Neurological | Not drowsy; pupils normal size |
| Psychiatric | Tearful once; engaged; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic cough with daily yellow sputum, occasional streaks of blood, and breathlessness on stairs, worse in winter, for several years after an illness with blood in the sputum about eight years ago; tuberculosis, nontuberculous mycobacteria and bronchiectasis to be distinguished | resolved | confirmed | R05.3 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; it echoes her documented chest illness (D). |
| Non-cystic fibrosis bronchiectasis of the left lower lobe and lingula with chronic Haemophilus influenzae infection and mild airflow obstruction (Bronchiectasis Severity Index 3, mild); tuberculosis and nontuberculous mycobacterial disease excluded; synthetic modern diagnosis chosen for a historical chest illness whose cause is disputed | active | confirmed | J47.9 | S — Synthetic modern diagnosis; the nature of her historical chest illness remains undetermined (R, disputed). |
| Long-term prescribed opioid therapy (oral morphine 20 mg a day for many years, for cough, sleeplessness and palpitations), with expected physiological dependence; no opioid use disorder on DSM-5-TR assessment | active | confirmed | Z79.891 | S — Synthetic modern problem anchored to her documented prescribed opium (D); tolerance and withdrawal on prescribed opioids do not count toward opioid use disorder. |
| Prolonged grief disorder after the drowning of her closest brother five years ago, with yearning, self-blame, avoidance of reminders of the sea, and depressive symptoms (PHQ-9 12); no suicidal ideation | active | confirmed | F43.81 | S — Synthetic modern diagnosis anchored to her documented bereavement (D); not a claim about her real mental health. |
| Vitamin D deficiency (25-hydroxyvitamin D 15 ng/mL) in a woman who rarely goes outdoors | active | confirmed | E55.9 | S — Synthetic finding at intake; repleted by twelve weeks. |
| Underweight (BMI 16.8) with a small appetite | active | confirmed | R63.6 | S — Synthetic finding at intake. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Tuberculosis: acid-fast smear, nucleic acid amplification and culture on three sputum samples; interferon-gamma release assay | Once, at diagnosis | Completed today | Three sputum smears and NAAT negative; IGRA negative; HIV negative: tuberculosis very unlikely; masking stopped |
| Laboratory | Mycobacterial culture including nontuberculous mycobacteria | At diagnosis (final at six to eight weeks), then yearly and with unexplained decline | Ordered | Cultures from the three samples in progress |
| Imaging | CT of the chest | Once, to confirm the diagnosis | Completed today | Cylindrical bronchiectasis of the left lower lobe and lingula; no cavity, nodule, mass or sequestration |
| Laboratory | Cause of bronchiectasis: blood count, IgG, IgA and IgM, total IgE and Aspergillus-specific IgE | Once, at diagnosis; cystic fibrosis, ciliary and connective tissue tests only if the history suggests them | Completed today | Blood count normal at the first visit; IgG 1180, IgA 236, IgM 142 mg/dL; total IgE 38 IU/mL; Aspergillus IgE 0.08 kU/L: no immune deficiency or allergic aspergillosis; no features suggesting cystic fibrosis, a ciliary disorder or connective tissue disease |
| Laboratory | Sputum bacterial culture | At each review and at every exacerbation, before antibiotics | Completed today | First-visit culture: Haemophilus influenzae, beta-lactamase negative; no Pseudomonas |
| Imaging | Spirometry and Bronchiectasis Severity Index | At diagnosis, then yearly | Completed today | FEV1 2.02 L (74% predicted), FVC 2.93 L, FEV1/FVC 0.69 after bronchodilator; Bronchiectasis Severity Index 3, mild |
| Self-management | Airway clearance technique and exercise | Every visit | Ordered | Physiotherapy teaching session booked this week |
| Self-management | Exacerbations: number in the past year, written plan, and rescue antibiotic | Every visit | Completed today | About two winter chest infections a year by her account; written plan and rescue antibiotic given; long-term macrolide not indicated |
| Self-management | Hemoptysis: amount, and when to seek emergency care | Every visit | Completed today | One streak three days ago; emergency rules repeated |
| Self-management | Influenza and pneumococcal vaccines | Influenza yearly; pneumococcal once | Due | Pneumococcal vaccine at the next preventive visit; influenza in the autumn |
| Medication safety | Opioid benefits and harms: function, sleep, cough, sedation, breathing, constipation, and her goals | Every visit, and at least every three months | Completed today | No sedation; cough suppression discussed; no change |
| Medication safety | Naloxone at home, and no benzodiazepines or other sedatives | Every visit | Completed today | Two naloxone devices at home; no sedatives |
| Survey | PHQ-9 | At least monthly during active treatment (CMID) | Up to date | 12 one week ago; next at four weeks |
| Examination | Suicide risk review and safety plan | Every visit | Completed today | No suicidal ideation; locked box in use |
| Referral | Pulmonology review | At diagnosis, then as advised | Completed today | Seen by Dr. Ellesmere-Park this morning |
Goal progress:
Guideline basis: British Thoracic Society Guideline for Bronchiectasis in Adults (2019); European Respiratory Society guidelines for the management of adult bronchiectasis (2017); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression and osteoporosis monographs (2026)
Follow-up: Four-week review with the mycobacterial culture progress, sputum culture, DXA, PHQ-9 and the opioid plan. Emergency care for more than a few teaspoons of blood. Next scheduled visit 2026-04-20: four-week review: mycobacterial cultures, airway clearance, bone density, grief therapy, and her choice about the opioid dose. [S]